1-aminocyclohexanecarboxylic acid has been researched along with 2-aminoisobutyric acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benedetti, E; Di Lello, P; Didierjean, C; Garella, I; Iacovino, R; Menchise, V; Montesarchio, D; Romanelli, A; Rossi, F; Saviano, M | 1 |
| Naydenova, ED; Staykova, STs; Vezenkov, LT; Wesselinova, DW | 1 |
| Danalev, D; Dzimbova, T; Naydenova, E; Staykova, S; Wesselinova, D | 1 |
3 other study(ies) available for 1-aminocyclohexanecarboxylic acid and 2-aminoisobutyric acid
| Article | Year |
|---|---|
Crystal-state conformation of Calpha,alpha-dialkylated peptides containing chiral beta-homo-residues.
Topics: Alkylation; Amino Acids; Amino Acids, Cyclic; Aminoisobutyric Acids; Crystallography, X-Ray; Cyclohexanecarboxylic Acids; Hydrogen Bonding; Magnetic Resonance Spectroscopy; Models, Molecular; Peptide Biosynthesis; Peptides; Protein Conformation; Protein Structure, Secondary | 2001 |
Synthesis and in vitro antitumor activity of new octapeptide analogs of somatostatin containing unnatural amino acids.
Topics: Amino Acid Sequence; Amino Acids, Cyclic; Aminoisobutyric Acids; Antineoplastic Agents; Biomimetic Materials; Cell Line, Tumor; Cell Survival; Cyclohexanecarboxylic Acids; Cycloleucine; Dose-Response Relationship, Drug; HeLa Cells; HT29 Cells; Humans; Molecular Sequence Data; Oligopeptides; Solid-Phase Synthesis Techniques; Somatostatin; Structure-Activity Relationship | 2015 |
Synthesis, in vitro biological activity and docking of new analogs of BIM-23052 containing unnatural amino acids.
Topics: Amino Acids; Amino Acids, Cyclic; Aminoisobutyric Acids; Antineoplastic Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; Cyclohexanecarboxylic Acids; Cycloleucine; HeLa Cells; HT29 Cells; Humans; Molecular Docking Simulation; Peptides; Receptors, Somatostatin; Somatostatin; Structure-Activity Relationship | 2019 |